The most impactful medtech headlines of 2023

Fast Five Medtech News Podcast

Today's episode is a roundup of some of the most impactful medtech headlines of 2023. We had a handful of news stories this year that caught our attention. Join Fast Five hosts Sean Whooley and Danielle Kirsh as they discuss the following: Layoffs – Medtech has shown some resilience in the present economic environment. Some major medical device companies released positive earnings this year. However, others announced headcount reductions, citing macroeconomic headwinds. Hear which companies reduced their workforce the most in 2023 and some of the reasons they listed for the reduction. Personnel moves – Contrary to layoffs, some big names in medtech executive leadership also left their posts for new jobs in 2023. Some of our top stories were about CEOs leaving for a new company, retiring or another reason. Whooley and Kirsh discuss some of the largest personnel moves that shook the industry this year, including J&J MedTech's leadership change. Silicon Valley Bank closure – Silicon Valley Bank’s closure in March affected several medtech companies. SVB has been a huge name in the tech and startup world since its founding in the 1990s. The Fast Five hosts talk about the companies that were backed by SVB and the surprising story of a medtech company that benefitted from the closure. Mergers & acquisitions – Medtech had some pricey acquisitions in 2023. Despite some macroeconomic challenges, M&A activity was seemingly up for the year. Hear about one of the largest deals of the year and some of the other deals in medtech in 2023. Brain-computer interfaces – Many companies joined the playing field for that technology or had breakthroughs in 2023. Blackrock Neurotech, BrainGate, ClearPoint Neuro, Neuralink, Synchron and more race to bring brain-computer interface (BCI) tech to market. Learn about the top companies in the BCI space and what their technology does.